Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,378,774 papers from all fields of science
Search
Sign In
Create Free Account
Proprotein Convertase 9
Known as:
Convertase 9, Proprotein
, Proprotein Convertase, Subtilisin Kexin Type 9
, Proprotein Convertase 9 [Chemical/Ingredient]
Expand
A proprotein convertase that is essential for CHOLESTEROL homeostasis. It binds to and is required for the lysosomal degradation of the LDL RECEPTOR…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
9 relations
In Blood
PCSK9 gene
Process of secretion
antagonists & inhibitors
Expand
Narrower (1)
PCSK9 protein, human
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
On the function and homeostasis of PCSK9: reciprocal interaction with LDLR and additional lipid effects.
H. Tavori
,
S. Rashid
,
S. Fazio
Atherosclerosis
2015
Corpus ID: 205722051
Highly Cited
2014
Highly Cited
2014
Compositional studies and biological activities of some mash bean (Vigna mungo (L.) Hepper) cultivars commonly consumed in Pakistan
M. Zia‐ul‐Haq
,
Shakeel Ahmad
,
S. Bukhari
,
R. Amarowicz
,
S. Ercişli
,
H. Jaafar
Biological Research
2014
Corpus ID: 9201086
BackgroundIn recent years, the desire to adopt a healthy diet has drawn attention to legume seeds and food products derived from…
Expand
Highly Cited
2012
Highly Cited
2012
Peroxisome Proliferator-activated Receptor γ Activation by Ligands and Dephosphorylation Induces Proprotein Convertase Subtilisin Kexin Type 9 and Low Density Lipoprotein Receptor Expression*
Yajun Duan
,
Yuanli Chen
,
+10 authors
Jihong Han
Journal of Biological Chemistry
2012
Corpus ID: 23646961
Background: PCSK9 regulates cholesterol homeostasis by enhancing the LDLR protein degradation. The effects of PPARγ on PCSK9 and…
Expand
Review
2011
Review
2011
Clinical aspects of PCSK9.
B. Cariou
,
C. Le May
,
P. Costet
Atherosclerosis
2011
Corpus ID: 38257434
Review
2009
Review
2009
Molecular basis of PCSK9 function.
G. Lambert
,
F. Charlton
,
K. Rye
,
D. E. Piper
Atherosclerosis
2009
Corpus ID: 38129493
Highly Cited
2009
Highly Cited
2009
Inhibition of PCSK9: A powerful weapon for achieving ideal LDL cholesterol levels
D. Steinberg
,
J. Witztum
Proceedings of the National Academy of Sciences…
2009
Corpus ID: 28306774
Plasma LDL cholesterol level is a major determinant of cardiovascular disease (CVD) risk. The striking results of the early large…
Expand
Highly Cited
2009
Highly Cited
2009
Degradation of LDLR protein mediated by 'gain of function' PCSK9 mutants in normal and ARH cells.
T. Fasano
,
Xi‐Ming Sun
,
D. Patel
,
A. Soutar
Atherosclerosis
2009
Corpus ID: 205712518
Review
2008
Review
2008
PCSK9 and LDL cholesterol: unravelling the target to design the bullet.
P. Costet
,
M. Krempf
,
B. Cariou
TIBS -Trends in Biochemical Sciences. Regular ed
2008
Corpus ID: 10725942
Highly Cited
2008
Highly Cited
2008
Identification and characterization of two non-secreted PCSK9 mutants associated with familial hypercholesterolemia in cohorts from New Zealand and South Africa.
V. Homer
,
A. Marais
,
+10 authors
Gilles Lambert
Atherosclerosis
2008
Corpus ID: 36850102
Highly Cited
2006
Highly Cited
2006
Fasting induces hyperlipidemia in mice overexpressing proprotein convertase subtilisin kexin type 9: lack of modulation of very-low-density lipoprotein hepatic output by the low-density lipoprotein…
G. Lambert
,
Anne-Laure Jarnoux
,
+5 authors
P. Costet
Endocrinology
2006
Corpus ID: 27631506
Several proprotein convertase subtilisin kexin type 9 (PCSK9) mutations lead to familial hypercholesterolemia by virtue of its…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE